The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Grifols Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
10 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - General laboratoryware IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Instrument/analyser IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Analyser software IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology blood grouping antisera IVDs.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Alpha-1 proteinase inhibitor
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial (164550)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 10g in 200 mL human normal immunoglobulin solution for intravenous infusion vial.
-
INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial (164551)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 2.5g in 50mL human normal immunoglobulin solution for intravenous infusion vial.